Skip to main content
Book Chapter

Measuring disease activity and outcomes in clinical trials

Springer US, (2012), 661-671
DOI: 10.1007/978-1-4419-5774-0_55
2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Systemic sclerosis (Scleroderma, SSc) has seen substantial progress in the development and validation of outcome measures [1]. This chapter will discuss the outcome measures ready for clinical trials in SSc. Another chapter in this book will discuss the patient reported outcome measures in clinical practice (Chap. 56).

Author supplied keywords

Cite

CITATION STYLE

APA

Khanna, D. (2012). Measuring disease activity and outcomes in clinical trials. In Scleroderma: From Pathogenesis to Comprehensive Management (pp. 661–671). Springer US. https://doi.org/10.1007/978-1-4419-5774-0_55

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free